Cargando…

Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth

Background: Abdominal aortic aneurysm represents a distinct group of vascular lesions, in terms of surveillance and treatment. Screening and follow-up of patients via duplex ultrasound has been well established and proposed by current guidelines. However, serum circulating biomarkers could earn a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Nana, Petroula, Dakis, Konstantinos, Brodis, Alexandros, Spanos, Konstantinos, Kouvelos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072679/
https://www.ncbi.nlm.nih.gov/pubmed/33923412
http://dx.doi.org/10.3390/jcm10081718
_version_ 1783683962643677184
author Nana, Petroula
Dakis, Konstantinos
Brodis, Alexandros
Spanos, Konstantinos
Kouvelos, George
author_facet Nana, Petroula
Dakis, Konstantinos
Brodis, Alexandros
Spanos, Konstantinos
Kouvelos, George
author_sort Nana, Petroula
collection PubMed
description Background: Abdominal aortic aneurysm represents a distinct group of vascular lesions, in terms of surveillance and treatment. Screening and follow-up of patients via duplex ultrasound has been well established and proposed by current guidelines. However, serum circulating biomarkers could earn a position in individualized patient surveillance, especially in cases of aggressive AAA growth rates. A systematic review was conducted to assess the correlation of AAA expansion rates with serum circulating biomarkers. Methods: A data search of English medical literature was conducted, using PubMed, EMBASE, and CENTRAL, until 7 March 2021, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement (PRISMA) guidelines. Studies reporting on humans, on abdominal aortic aneurysm growth rates and on serum circulating biomarkers were included. No statistical analysis was conducted. Results: A total of 25 studies with 4753 patients were included. Studies were divided in two broad categories: Those reporting on clinically applicable (8 studies) and those reporting on experimental (17 studies) biomarkers. Twenty-three out of 25 studies used duplex ultrasound (DUS) for following patients. Amongst clinically applicable biomarkers, D-dimers, LDL-C, HDL-C, TC, ApoB, and HbA1c were found to bear the most significant association with AAA growth rates. In terms of the experimental biomarkers, PIIINP, osteopontin, tPA, osteopontin, haptoglobin polymorphisms, insulin-like growth factor I, thioredoxin, neutrophil extracellular traps (NETs), and genetic factors, as polymorphisms and microRNAs were positively correlated with increased AAA expansion rates. Conclusion: In the presence of future robust data, specific serum biomarkers could potentially form the basis of an individualized surveillance strategy of patients presenting with increased AAA growth rates.
format Online
Article
Text
id pubmed-8072679
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80726792021-04-27 Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth Nana, Petroula Dakis, Konstantinos Brodis, Alexandros Spanos, Konstantinos Kouvelos, George J Clin Med Review Background: Abdominal aortic aneurysm represents a distinct group of vascular lesions, in terms of surveillance and treatment. Screening and follow-up of patients via duplex ultrasound has been well established and proposed by current guidelines. However, serum circulating biomarkers could earn a position in individualized patient surveillance, especially in cases of aggressive AAA growth rates. A systematic review was conducted to assess the correlation of AAA expansion rates with serum circulating biomarkers. Methods: A data search of English medical literature was conducted, using PubMed, EMBASE, and CENTRAL, until 7 March 2021, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement (PRISMA) guidelines. Studies reporting on humans, on abdominal aortic aneurysm growth rates and on serum circulating biomarkers were included. No statistical analysis was conducted. Results: A total of 25 studies with 4753 patients were included. Studies were divided in two broad categories: Those reporting on clinically applicable (8 studies) and those reporting on experimental (17 studies) biomarkers. Twenty-three out of 25 studies used duplex ultrasound (DUS) for following patients. Amongst clinically applicable biomarkers, D-dimers, LDL-C, HDL-C, TC, ApoB, and HbA1c were found to bear the most significant association with AAA growth rates. In terms of the experimental biomarkers, PIIINP, osteopontin, tPA, osteopontin, haptoglobin polymorphisms, insulin-like growth factor I, thioredoxin, neutrophil extracellular traps (NETs), and genetic factors, as polymorphisms and microRNAs were positively correlated with increased AAA expansion rates. Conclusion: In the presence of future robust data, specific serum biomarkers could potentially form the basis of an individualized surveillance strategy of patients presenting with increased AAA growth rates. MDPI 2021-04-16 /pmc/articles/PMC8072679/ /pubmed/33923412 http://dx.doi.org/10.3390/jcm10081718 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nana, Petroula
Dakis, Konstantinos
Brodis, Alexandros
Spanos, Konstantinos
Kouvelos, George
Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title_full Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title_fullStr Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title_full_unstemmed Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title_short Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth
title_sort circulating biomarkers for the prediction of abdominal aortic aneurysm growth
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072679/
https://www.ncbi.nlm.nih.gov/pubmed/33923412
http://dx.doi.org/10.3390/jcm10081718
work_keys_str_mv AT nanapetroula circulatingbiomarkersforthepredictionofabdominalaorticaneurysmgrowth
AT dakiskonstantinos circulatingbiomarkersforthepredictionofabdominalaorticaneurysmgrowth
AT brodisalexandros circulatingbiomarkersforthepredictionofabdominalaorticaneurysmgrowth
AT spanoskonstantinos circulatingbiomarkersforthepredictionofabdominalaorticaneurysmgrowth
AT kouvelosgeorge circulatingbiomarkersforthepredictionofabdominalaorticaneurysmgrowth